Globally, more than 34 million people are infected with HIV; in sub-Saharan Africa alone, 3 million new infections occur annually.
In an attempt to stop the spread of HIV, governments in the region are considering providing antiretroviral drugs to people who do not have the virus but are at risk for becoming infected, researchers said.
Such drugs are known as pre-exposure prophylaxis, or PrEP.
The strategy, developed using a complex mathematical model, focuses on targeting "hot zones".
In South Africa, where 17 per cent of the population is infected with HIV, the model predicted that targeting hot zones would prevent 40 per cent more HIV infections than using the conventional strategy - and would therefore be 40 per cent more cost-effective.
The model featured three important components: the geographic dispersion of the population, the geographic variation in the severity of the HIV epidemic and the geographic variation in the level of risk behaviour.
The model revealed that two of South Africa's nine provinces are hot zones.
The researchers then used the model to predict where, and how many, new HIV infections would occur based on using either the conventional strategy or a strategy targeting hot zones for distributing the drugs.
"The methods we developed can be used to find hot zones in any other sub-Saharan countries that have geographic variation in the severity of their HIV epidemic, such as Lesotho, Botswana, Nigeria and Uganda," said David Gerberry, the study's first author and a former UCLA postdoctoral fellow who now is an assistant professor in mathematics at Xavier University.
The study appears in the journal Nature Communications.
